Zymeworks ZYME
NASDAQ ZYME
$29.28 -0.62 (-2.07%)
As of: Sep 4, 2026 · 12:45 PM EDT

Zymeworks (ZYME) Other Operating Expenses (2022 - 2026)

Zymeworks (ZYME) posted Other Operating Expenses of $765000.0 for Q1 2026, down 71.38% sequentially from $2.7 million in Q4 2025, and down 77.97% YoY from $3.5 million in Q1 2025.

Analysis

Zymeworks (ZYME) Other Operating Expenses (2022 - 2026) Analysis & Trends

Zymeworks has reported Other Operating Expenses for 5 years, with the latest figure at $765000.0 in Q1 2026.

  • Quarterly Other Operating Expenses fell 77.97% year-over-year to $765000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (down 43.17% YoY) and the FY2025 annual result came in at $12.8 million, down 37.58% from the prior year.
  • Other Operating Expenses declined to $765000.0 in Q1 2026 per ZYME's latest filing, from $2.7 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $6.2 million in Q1 2024 and troughed at -$13000.0 in Q1 2022.
  • A 5-year average of $3.4 million and a median of $3.8 million in 2025 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2023 and 2026: Other Operating Expenses jumped 33315.38% in 2023, then tumbled 77.97% in 2026.
  • Over 5 years, Other Operating Expenses stood at $1.0 million in 2022, then jumped by 305.09% to $4.2 million in 2023, then grew by 4.96% to $4.4 million in 2024, then slumped by 39.61% to $2.7 million in 2025, then slumped by 71.38% to $765000.0 in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered $765000.0, $2.7 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Zymeworks 2.14 Bn 1.87 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.11 Mn
Mar 31, 2026 765,000.00
Dec 31, 2025 2.67 Mn
Sep 30, 2025 3.84 Mn
Jun 30, 2025 2.81 Mn
Mar 31, 2025 3.47 Mn
Dec 31, 2024 4.43 Mn
Sep 30, 2024 4.58 Mn
Jun 30, 2024 5.27 Mn
Mar 31, 2024 6.22 Mn
Dec 31, 2023 4.22 Mn
Sep 30, 2023 5.66 Mn
Jun 30, 2023 4.62 Mn
Mar 31, 2023 4.32 Mn
Dec 31, 2022 1.04 Mn
Sep 30, 2022 2.48 Mn
Jun 30, 2022 1.20 Mn
Mar 31, 2022 -13,000.00